IDH1-AS1: A Potential Drug Target and Biomarker (G100507475)

Target Name: IDH1-AS1

NCBI ID: G100507475

IDH1-AS1

Other Name(s): IDH1 antisense RNA 1

IDH1-AS1: A Potential Drug Target and Biomarker

IDH1-AS1, also known as INK4a, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to investigate, and its functions continue to elicit interest from the scientific community.

IDH1-AS1 Expression

IDH1-AS1 is a transcribed RNA molecule that is primarily expressed in the brain, heart, and testes. Its expression has been associated with various neurological and psychiatric diseases, including Alzheimer's disease, Parkinson's disease, and mental retardation.

IDH1-AS1 has been shown to play a role in the development and progression of cancer, particularly in the regulation of cell proliferation and apoptosis. It has been shown to promote the growth and survival of cancer cells, and it has also been shown to inhibit the inhibition of cell proliferation in cancer cells.

IDH1-AS1 as a Potential Drug Target

The potential drug target for IDH1-AS1 is based on its role in cancer development and its expression in various diseases. Drugs that target IDH1-AS1 have the potential to inhibit its activity and reduce the growth and spread of cancer cells.

IDH1-AS1 has been shown to play a role in the regulation of the DNA damage response, a critical process that helps maintain the stability of the genetic material. Mutations in the DNA damage response have been linked to various diseases, including cancer.

Targeting IDH1-AS1

Drugs that target IDH1-AS1 have the potential to inhibit its activity and reduce the growth and spread of cancer cells. This can be achieved through various mechanisms, including inhibition of IDH1-AS1 translation, inhibition of IDH1-AS1-mediated signaling pathways, or inhibition of IDH1-AS1-associated processes.

One approach to targeting IDH1-AS1 is through inhibition of its activity as a protein kinase. IDH1-AS1 has been shown to play a role in the regulation of the DNA damage response, and it has been shown to promote the growth and survival of cancer cells. Drugs that inhibit IDH1-AS1 activity as a protein kinase could potentially inhibit its ability to promote cancer cell growth and spread.

Another approach to targeting IDH1-AS1 is through inhibition of its activity as a negative regulator of the microtubule network. IDH1-AS1 has been shown to play a role in regulating the microtubule network, and it has been shown to promote the growth and survival of cancer cells. Drugs that inhibit IDH1-AS1 activity as a microtubule network regulator could potentially inhibit its ability to promote cancer cell growth and spread.

IDH1-AS1 as a Biomarker

IDH1-AS1 has also been identified as a potential biomarker for various diseases, including cancer. Its unique expression pattern and functions have made it an attractive target for researchers to investigate.

IDH1-AS1 has been shown to be expressed in various tissues and organs, including the brain, heart, and testes. Its expression has also been associated with various diseases, including cancer. This suggests that IDH1-AS1 may be a useful biomarker for cancer diagnosis and treatment.

IDH1-AS1 has also been shown to play a role in the regulation of the DNA damage response, a critical process that helps maintain the stability of the genetic material. This suggests that IDH1-AS1 may be a useful biomarker for assessing the severity of DNA damage in various diseases, including cancer.

Conclusion

In conclusion, IDH1-AS1 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and expression pattern have made it an attractive target for researchers to investigate, and its functions continue to elicit interest from the scientific community. Further research is needed to fully understand the role of IDH1-AS1 in

Protein Name: IDH1 Antisense RNA 1

The "IDH1-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IDH1-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets